Rifampin-divalproex drug-drug interaction in an adult patient: A case report

The divalproex (DVP) package insert states that rifampin may increase the oral clearance of valproate by 40% and that valproic acid derivative dose adjustments may be required when starting or stopping rifampin. However, the overall clinical significance of this drug-drug interaction remains unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Doran, Christine, Moro, Michael, Green, Jennifer, Gardner, Kristen N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800327/
https://www.ncbi.nlm.nih.gov/pubmed/33505821
http://dx.doi.org/10.9740/mhc.2021.01.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800327/
https://www.ncbi.nlm.nih.gov/pubmed/33505821
http://dx.doi.org/10.9740/mhc.2021.01.019

Ejemplares similares